Inhibitory Effect of Full-Length Human Endostatin on in Vitro Angiogenesis
Authors:
- Paola ChiarugiaPCPaola Chiarugia
- Laura BrogellibLBLaura Brogellib
- Paolo CirriaPCPaolo Cirria
- Lucia MagnellicLMLucia Magnellic
- Giovanni RaugeiaGRGiovanni Raugeia
- Marina ZichebMZMarina Zicheb
- Harris J. GrangerHGHarris J. Granger
- Vincenzo ChiarugicVCVincenzo Chiarugic
- Giampietro RamponiGRGiampietro Ramponi
- 1 September 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 263 (2) , 340-345
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Mechanisms of angiogenesisNature, 1997
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995
- Endothelial receptor tyrosine kinases involved in angiogenesis.Journal of Cell Biology, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Angiogenesis.Journal of Biological Chemistry, 1992
- Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells.Proceedings of the National Academy of Sciences, 1989
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983